Rafferty Asset Management
VANI icon

Rafferty Asset Management’s Vivani Medical VANI Stock Holding History

Rafferty Asset Management’s Portfolio VANI Stock Details VANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-11,328
Closed -$55K – 1325
2021
Q4 		$55K Buy
11,328
+2,283
+25% +$16.7K ﹤0.01% 1283
2021
Q3 		$87K Buy
+9,045
New +$102K ﹤0.01% 1239

Other funds holding VANI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Rafferty Asset Management's VANI Position: Q1 2022 in Review

Rafferty Asset Management sold out of Vivani Medical (VANI) in Q1 2022, closing a stake of 11,328 shares — an estimated $55K sold.

Rafferty Asset Management first reported a position in VANI in Q3 2021 and held it in 2 quarters. The position peaked at $87K in Q3 2021. 28 funds tracked by Wall St. Rank hold VANI as of Q1 2022.

  • Rafferty Asset Management reported no remaining Vivani Medical position as of Q1 2022 after selling out during the quarter.
  • Rafferty Asset Management sold 11,328 Vivani Medical shares in Q1 2022, an estimated $55K.
  • Rafferty Asset Management first reported a position in Vivani Medical in Q3 2021 and held it in 2 quarters.
  • Rafferty Asset Management's Vivani Medical position peaked at $87K in Q3 2021.
  • 28 funds tracked by Wall St. Rank held Vivani Medical as of Q1 2022.

Based on Rafferty Asset Management's 13F filing for Q1 2022, filed 13 May 2022.